2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide

2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Suppliers list
Company Name: 3B Pharmachem (Wuhan) International Co.,Ltd.  
Tel: 18930552037
Email: 3bsc@sina.com
Company Name: VDM Biochemicals   
Tel: 0330-2528181
Email: sales@vdmbio.com
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Shanghai SunSyn Pharmaceutical Co., Ltd.  
Tel: 021-18621020637 18621020637
Email: sales@sunsynpharma.com
Company Name: Shanghai Macklin Biochemical Co.,Ltd.  
Tel: 15221275939 15221275939
Email: shenlinxing@macklin.cn

2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide manufacturers

  • HC-067047
  • HC-067047 pictures
  • $30.00
  • 2026-07-14
  • CAS:883031-03-6
  • Purity: 99.89%
  • Supply Ability: 10g
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Basic information
Product Name:2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide
Synonyms:2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide;HC 067047;2-methyl-1-(3-morpholin-4-ylpropyl)-5-phenyl-N-[3-(trifluoromethyl)phenyl]pyrrole-3-carboxamide;1H-Pyrrole-3-carboxamide, 2-methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-;HC-067047 >=98% (HPLC);Transient receptor potential channels,HC-067047,Inhibitor,HC 067047,TRP Channel,inhibit;HC 067047, TRPV4 antagonist;HC-067047, 10 mM in DMSO
CAS:883031-03-6
MF:C26H28F3N3O2
MW:471.51
EINECS:
Product Categories:Potent and selective TRPV4 antagonist.
Mol File:883031-03-6.mol
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Structure
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Chemical Properties
storage temp. 2-8°C
solubility DMSO: ≥15mg/mL
form powder
color white to tan
Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
InChIKeyNCZYSQOTAYFTNM-UHFFFAOYSA-N
SMILESCC1=C(C(NC2=CC(C(F)(F)F)=CC=C2)=O)C=C(C3=CC=CC=C3)N1CCCN4CCOCC4
Safety Information
Hazard Codes T
Risk Statements 25-36
Safety Statements 26-45
RIDADR UN 2811 6.1 / PGIII
WGK Germany 3
Storage Class11 - Combustible Solids
MSDS Information
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Usage And Synthesis
DescriptionHC-067047 (883031-03-6) is a potent reversible and selective TRPV4 blocker. Active at mouse, human and rat TRPV4, IC50= 17, 48 and 133 nM respectively. Also inhibits the endogenous TRPV4-mediated response to 4α-PDH (IC50 = 22 nM). Selective for TRPV4 over TRPV1, TRPV2, TRPV3 and TRPM8 channels.1 Increases functional bladder capacity and reduces micturition frequency in mice and rats with cystitis.1 Inhibits brain edema in middle cerebral artery occlusion mice.2 HC-067047 induces an increase in core body temperature accompanied by increased oxygen consumption in Wistar rats.3Activein vivo.
UsesHC-067047has been used as a transient receptor potential cation channel subfamily V member 4 (TRPV4)inhibitor:
  • to study its effects on organoid formation and proliferation in human endometrial tissues
  • to determine its effects on neuronal survival after intracerebral hemorrhage (ICH)
  • to study its effects on TRPV4 regulation of angiotensin II receptor type 1 (AT1R) task, phosphorylation and β-arrestin recruitment in choroid plexus

Biochem/physiol ActionsHC-067047 is a potent, selective inhibitor of hTRPV4. The compound inhibits human, rat and mouse TRPV4 with IC50 values of 48, 133 and 17 nM, respectively. HC-067047 does not inhibit other TRPV isoforms at concentrations up to 5 μM. HC-067047 inhibits hERG channel and the menthol receptor TRPM8 with IC50 values of 370 and 780 nM, respectively.
in vivo

HC-067047 (0-50 mg/kg; intraperitoneal injection; for 30 minutes; cyclophosphamide-treated WT and Trpv4 / mice, and naive WT mice) treatment increases functional bladder capacity and reduces micturition frequency in WT mice with cystitis. HC-067047 do not affect bladder function in Trpv4 / mice[1].

Animal Model:Cyclophosphamide-treated WT and Trpv4/ mice, and naive WT mice[1]
Dosage:0 mg/kg, 1 mg/kg, 10 mg/kg, 50 mg/kg
Administration:Intraperitoneal injection; for 30 minutes
Result:Increased functional bladder capacity and reduces micturition frequency in WT mice with cystitis and did not affect bladder function in Trpv4/ mice.
storage+4°C
References[1] WOUTER EVERAERTS. Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2010: 19084-19089. DOI:10.1073/pnas.1005333107
[2] PINGHUI JIE. Blockage of transient receptor potential vanilloid 4 inhibits brain edema in middle cerebral artery occlusion mice.[J]. Frontiers in Cellular Neuroscience, 2015: 141. DOI:10.3389/fncel.2015.00141
[3] R. C. L. VIZIN. TRPV4 activates autonomic and behavioural warmth-defence responses in Wistar rats[J]. Acta Physiologica, 2015, 214 2: 275-289. DOI:10.1111/apha.12477
2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide Preparation Products And Raw materials
Tag:2-Methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide(883031-03-6) Related Product Information
Minoxidil 1-[4-[(2,3,3-Trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylicacid 2-Propenoic acid, 3,3'-(1,3-phenylene)bis- 2-[2-[4-(4-Nitrobenzyloxy)phenyl]ethyl]isothiourea mesylate Fantofarone HC TOXIN